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Abstract
Background: An atypical type A thymoma variant was newly added to the WHO classification of type A thymoma
family in 2015.
Case presentation: A 72-year-old female was present a large round mass in the anterior mediastinum. The
radiological examination led to a preoperative diagnosis of non-invasive thymoma. Tumor resection was undertaken
via median sternotomy. Complete removal of the mediastinal tumor was achieved. Pathological examination revealed
that the tumor cells were spindle- and oval-shaped with atypia. Immunohistochemical work-up revealed that the
tumor was type A thymoma. On the basis of these findings, the tumor was finally diagnosed to be an atypical type A
thymoma variant.
Conclusions: Preoperative diagnosis as atypical type A thymoma variant based on radiological examination is difficult.
In case of atypical type A thymoma variant, a careful postoperative systemic follow-up should be done.
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Background
In general, type A thymoma is recognized as a benign
tumor with excellent prognosis [1]. However, several au-
thors have reported type A thymoma showing atypical
features with postoperative tumor relapse [2–4]. On the
basis of these reports, atypical type A thymoma variant
was added to the type A thymoma family as a small sub-
set of aggressive tumors [5, 6]. Here, we present the case
of an atypical type A thymoma variant.
Case presentation
A 72-year-old female presented with a mediastinal mass
that was incidentally detected on chest X-ray (Fig. 1a).
Chest computed tomography (CT) revealed a large
round mass of 7.7 cm in diameter in the anterior medi-
astinum. Contrast-enhanced CT (CE-CT) revealed that
the mediastinal mass was not invading the surrounding
organs (Fig. 1b). Fluorodeoxyglucose positron emission
tomography (FDG-PET) showed mild uptake, with a
maximum standardized uptake value (SUVmax) of 3.5 at
the mediastinal mass (Fig. 1c). Abnormal uptake in other
organs, which may lead to a suspicion of distant
metastasis, was not detected. She did not present with
myasthenia gravis or any other autoimmune diseases.
Our preoperative diagnosis was a non-invasive thym-
oma, and she underwent tumor resection via median
sternotomy. The operative findings revealed that the
tumor did not invade the surrounding organs, and we
could easily dissect the tumor.
Pathological findings showed that the tumor was sur-
rounded by a fibrous capsule (Fig. 2a), and its cells were
spindle- and oval-shaped (Fig. 2b). A hemangiopericytoma-
like vascular pattern was present. The tumor cells showed
mild atypia, hypercellularity, and moderate mitotic activity
(8–10 mitoses per 2 mm2). Necrosis was absent (Fig. 2c). A
significant reticulin network was found around individual
tumor cells. In the immunohistochemical work-up, the
tumor cell was positive for AE1/AE3, p40, and CK5/6 and
negative for CD5 and c-kit. CD20 expression was detected
in some tumor cells (Fig. 3a). In the terminal deoxynucleo-
tidyl transferase (TdT) staining, a few TdT+T cells were
found in the tumor (Fig. 3b). The Ki-67 labeling index was
23.3 % (Fig. 3c). On the basis of these findings, the tumor
was finally diagnosed to be an atypical type A thymoma
variant.
Her postoperative course was uneventful, and she was
discharged on foot 12 days after surgery. She is doing
well without recurrence until last follow-up at 15 months
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Fig. 1 Chest X-ray showing an abnormal shadow in the mediastinum (a). Contrast-enhanced chest computed tomography showing a large round
mass not invading the surrounding organs in the anterior mediastinum (b). Fluorodeoxyglucose positron emission tomography showing a mild
hypermetabolic mass in the anterior mediastinum (c)
Fig. 2 Microscopic findings on hematoxylin–eosin staining showing encapsulated (a), the spindle- and oval-shaped tumor cells with hypercellurality,
moderate atypia, and high mitotic activity (arrowhead) (b, c)
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after operation. We continue to conduct careful postop-
erative follow-up.
Discussion
An atypical type A thymoma variant was added to the
WHO classification of type A thymoma family in 2015
[5] based on several reports about type A thymoma with
oncological aggressive behavior and tumor relapses [2–
4]. Pathological findings present the most specific fea-
ture of atypical type A thymoma. These are as follows:
(1) mild to moderate nuclear atypia, (2) increase in mi-
totic activity, and (3) a scattered foci of necrosis. These
findings are usually present in type B3 thymoma rather
than the conventional type A thymoma. Vladislav and
coworkers described that the frequency of type A thym-
oma with these aggressive behavior was 3.8 % (23/600
cases) [2]. In this case, the patient presented with mild
atypia, hypercellularity, and high mitotic activity, which
was 8–10 mitoses per 2 mm2. This distribution was
denser than conventional type A thymoma where the
count is usually <4 mitoses per 2 mm2.
On the other hand, specific finding of radiological
examination was still unknown. CECT could show the
possibility of tumor invasiveness to surrounding organ,
but it would not reflect of morphological behavior. Re-
cently, PET-CT has been known as a useful examination
about thymic epithelial tumors, especially thymoma [7, 8].
Park and coworkers showed that significant relationship
was observed between SUVmax and WHO classification,
mean SUVmax in low-risk thymoma (A, AB, and B1)
was 3.43, and high-risk thymoma (B2 and B3) was
4.42 [7]. However, in this case, SUVmax was 3.5; it
might not be able to predict the morphological be-
havior. As these results, neither CECT nor PET-CT
contributes preoperative definitive diagnosis of atypical
type A thymoma variant.
Vladislav and coworkers showed that tumor relapse,
including distant metastases, occurred in 43 % (10/23
patients) cases of type A thymoma showing atypical fea-
tures [2]. This relapse rate is much higher than that of
conventional type A thymoma.
The mean duration of time to metastases was
39.7 months (7–107 months). Of these 10 patients, lung
metastasis was found in 5, and liver metastasis in 4. Re-
garding surgical margin and postoperative tumor metas-
tasis, contrary to logic, development of metastatic
disease was observed more frequently in the patients
with negative surgical margin than positive or close
(<1 mm) surgical margin. And they also described that
only the presence of necrosis is a predictive factor of
tumor relapse, including distant metastases, and no
other factors such as the stage of diagnosis, tumor size,
nuclear shape, nuclear variability, and mitotic activity
correlate with tumor relapse. These suggested that post-
operative follow-up about not only intrathoracic cavity
but also extrathoracic cavity is essential.
Fig. 3 Microscopic findings on immunohistochemical staining aberrant expression for CD20 (a). Positive for terminal deoxynucleotidyl transferase
in a few tumor cells (b). Ki-67 labeling index was 23.3 % (c)
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Ki-67 is a well-known histological marker of prolifera-
tion used as an index of biological aggressiveness in vari-
ous solid tumors. It has already been reported that Ki-67
labeling index (LI) correlates with the tumor aggressive-
ness in thymic epithelial neoplasm [9]. In that report,
Ki-67 LI in type A thymoma was 0.3–11.0 % (median
3.0) and in thymic carcinoma was 12.2–43.3 % (median
23.2 %) [9]. Ki-67 LI in the present case was 23.3 %,
which suggests that the aggressiveness of this tumor is
similar to that of thymic carcinoma. The correlation be-
tween Ki-67 LI and tumor relapse in thymoma is not
confirmed, but careful postoperative follow-up may be
essential in atypical type A thymoma variant.
Conclusions
Here, we presented the case of an atypical type A thym-
oma variant. It is notable that radiological examination
did not contribute to the definitive diagnosis of the atyp-
ical type A thymoma variant. When we encounter the
case of atypical type A thymoma variant, careful postop-
erative systemic follow-up should be conducted.
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